NCT02358031 2025-07-18MK-3475-048Merck Sharp & Dohme LLCPhase 3 Completed882 enrolled 50 charts 1 FDA
NCT03189719 2024-10-15KEYNOTE-590Merck Sharp & Dohme LLCPhase 3 Completed749 enrolled 40 charts 1 FDA
NCT02335411 2022-08-08KEYNOTE-059Merck Sharp & Dohme LLCPhase 2 Completed318 enrolled 24 charts 1 FDA